Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor drugs

18 medications in the FDA established pharmacologic class “Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor”.

DrugTypeNDC products
EtravirineRx13
NevirapineRx9
EfavirenzRx8
Efavirenz, emtricitabine and tenofovir disoproxil fumarateRx7
Intelence
etravirine
Rx3
RilpivirineRx2
Pifeltro
doravirine
Rx2
Efavirenz, Lamivudine and Tenofovir Disoproxil FumarateRx2
Symfi
Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate
Rx1
Complera
emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate
Rx1
Odefsey
emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide
Rx1
Juluca
dolutegravir sodium and rilpivirine hydrochloride
Rx1
Idvynso
Doravirine, Islatravir
Rx1
Emtricitabine, Rilpivirine, Tenofovir Disoproxil FumarateRx1
emtricitabine, rilpivirine and tenofovir disoproxil fumarateRx1
Edurant Ped
rilpivirine hydrochloride
Rx1
Edurant
rilpivirine hydrochloride
Rx1
Delstrigo
doravirine, lamivudine, and tenofovir disoproxil fumarate
Rx1